Mazdutide
Also known as IBI362, LY3305677
Mazdutide is an experimental weekly injection that activates two hormones (GLP-1 and glucagon) to drive weight loss and improve blood sugar — glucagon adds an extra fat-burning angle.
One-dose burn-down
Half-life
5.4 days
Tmax
7.0 h
Steady state
~35d
Typical dose
1.5 mg
Investigational GLP-1 / glucagon receptor dual agonist (an oxyntomodulin analog) for obesity and diabetes. Once weekly.
Mechanism of action
Oxyntomodulin-based dual agonist pairing GLP-1 incretin effects with glucagon-mediated energy expenditure.
Investigational — not FDA approved. Half-life is poorly constrained in public data (reported ~7–45 days); treat the model as approximate.
Track Mazdutide for free
Log your doses and PeptideBuddy models Mazdutide's half-life into a live chart so you always know how much is active — plus reminders, reconstitution and protocol planning.
Start tracking free